Abstract |
The ectodermal dysplasia receptor (EDAR) is a recently isolated member of the tumor necrosis factor receptor family that has been shown to play a key role in the process of ectodermal differentiation. We present evidence that EDAR is capable of activating the nuclear factor-kappaB, JNK, and caspase-independent cell death pathways and that these activities are impaired in mutants lacking its death domain or those associated with anhidrotic ectodermal dysplasia and the downless phenotype. Although EDAR possesses a death domain, it did not interact with the death domain-containing adaptor proteins TRADD and FADD. EDAR successfully interacted with various TRAF family members; however, a dominant-negative mutant of TRAF2 was incapable of blocking EDAR-induced nuclear factor-kappaB or JNK activation. Collectively, the above results suggest that EDAR utilizes a novel signal transduction pathway. Finally, ectodysplasin A can physically interact with the extracellular domain of EDAR and thus represents its biological ligand.
|
Authors | A Kumar, M T Eby, S Sinha, A Jasmin, P M Chaudhary |
Journal | The Journal of biological chemistry
(J Biol Chem)
Vol. 276
Issue 4
Pg. 2668-77
(Jan 26 2001)
ISSN: 0021-9258 [Print] United States |
PMID | 11035039
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Ectodysplasins
- Membrane Proteins
- NF-kappa B
- Receptors, Tumor Necrosis Factor
- Protein Serine-Threonine Kinases
- JNK Mitogen-Activated Protein Kinases
- Mitogen-Activated Protein Kinases
- NF-kappa B kinase
|
Topics |
- Cell Death
- Ectodermal Dysplasia
- Ectodysplasins
- Enzyme Activation
- JNK Mitogen-Activated Protein Kinases
- Membrane Proteins
(metabolism)
- Mitogen-Activated Protein Kinases
(metabolism)
- Mutagenesis
- NF-kappa B
(metabolism)
- Protein Binding
- Protein Serine-Threonine Kinases
(metabolism)
- Receptors, Tumor Necrosis Factor
(genetics, metabolism)
- Signal Transduction
|